« Return to News | Awards & Advancement

Tengion adds renal experts to R&D advisory panel

Tuesday, March 29, 2011 12:19 PM

Tengion, a company involved in regenerative medicine, announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D., from the Harvard Stem Cell Institute and Giuseppe Remuzzi, M.D., F.R.C.P., from the Mario Negri Institute, to its panel of R&D advisors.

Remuzzi is the head of nephrology and dialysis and chairman of the department of transplantation at Bergamo Hospital and head of the Negri Bergamo Laboratories. He leads a team of researchers studying human renal diseases and their corresponding experimental models from the perspective of pathophysiology and therapeutic intervention.

Humphreys is an assistant professor of medicine at Harvard Medical School and principal faculty member of the Harvard Stem Cell Institute, where he is also co-director of the Institute’s Kidney Program. He is the recipient of a Harvard Stem Cell Institute Seed Grant, the National Kidney Foundation Young Investigator Award and the American Society of Nephrology Gottschalk Research Scholar Award. He investigates kidney repair for translation into therapies for kidney disease.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.